TAVI in Low Risk Patients - Prof Ravinay Bhindi
Debate TAVR Over SAVR in the Management of Young, Low risk Patients - PRO - Tarun Chakravaty, MD
TAVI in low-risk patients, what is required for TAVI to become the new gold standard?
How should we treat low risk patients with aortic stenosis? - Webinar
ACC 23: TAVR in Low-Risk Aortic Stenosis Patients: 3-Year Results From the Evolut Low Risk Trial
Dr. Robert Bonow discusses TAVR vs SAVR in low risk patients
TAVI, SAVR, PCI and low risk patients
EuroPCR 2016 Great Debate - extending TAVI to low risk patients: Lars Sondergaard
TAVI in low risk patients in a noninferiority model. Gotta be! - Geoff Puley
EuroPCR 2016 Great Debate - extending TAVI to low risk patients: Darren Mylotte
EuroPCR 21: TAVR for BAV Stenosis in Low Surgical Risk Patients
Transcatheter Aortic Valve Replacement (TAVR) for Low-Risk Patients
NOTION-2: TAVI vs. SAVR in younger low-risk patients with severe tricuspid/bicuspid aortic stenosis
TAVI in low risk patients in a noninferiority model. Gotta be! - James Velianou
CRT 2021 - 1-Year Bicuspid in Low-Risk TAVR
EuroPCR 2016 Great Debate - extending TAVI to low risk patients: Thomas Walther
Transcatheter Aortic Valve Replacement (TAVR) Expands to Low-Risk Patients
Highlights - Great Debate 2016 - extending TAVI to low risk patients
NOTION-2 trial: What are the implications for TAVI in young, low-risk patients with bicuspid valves
Debate TAVR Over SAVR in the Management of Young, Low risk Patients - CON - Ismail El-Hamamsy, MD
01 TAVR in the Low-Risk Patient: Are We There Yet? - Dustin Kliner, MD
EuroPCR 2016 Great Debate - extending TAVI to low risk patients: Jean François Obadia
S. Kapadia | TAVR for All? New insights from the low-risk trials
D. Angouras | Most Bicuspid aortic valves (especially In younger low-risk patients) will remain ...
TAVR procedure extended to low-risk patients
